Invokana 100 mg ? Canagliflozin Tablets | Type 2 Diabetes Treatment | Janssen

?? Product Description

Invokana 100 mg contains Canagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor used in the management of type 2 diabetes mellitus. Manufactured by Janssen Pharmaceuticals, it helps control blood sugar levels by promoting glucose excretion through urine. It is often used alongside diet and exercise to improve glycemic control.

?? Dosage & Administration

• Active Ingredient: Canagliflozin hemihydrate (equivalent to 100 mg Canagliflozin)

• Form: Film-coated Tablets

• Recommended Dose:

  • Usually 100 mg once daily, before the first meal

• Route: Oral

• Storage: Store below 30?C. Keep in a dry place and away from children

Packaging Details

• Brand Name: Invokana

• Manufacturer: Janssen Pharmaceuticals

• Pack Size: 3 strips of 10 tablets (30 tablets total)

• Prescription Required: Yes

?? Mechanism of Action

Canagliflozin works by inhibiting SGLT2 in the proximal renal tubules, reducing glucose reabsorption and increasing urinary glucose excretion. This helps lower plasma glucose concentrations independently of insulin.

?? Indications

• Type 2 Diabetes Mellitus

• For patients inadequately controlled by diet and exercise alone

• May be combined with Metformin, Sulfonylureas, DPP-4 inhibitors, or insulin

?? Precautions & Warnings

• Not for use in type 1 diabetes or diabetic ketoacidosis

• Risk of genital infections, urinary tract infections, and dehydration

• Monitor kidney function regularly

• May increase the risk of bone fractures and lower limb amputation in high-risk patients

• Avoid during pregnancy or breastfeeding unless prescribed by a doctor